CLINICAL RESEARCH e-ISSN 1643-3750 © Med Sci Monit, 2016; 22: 2616-2623 DOI: 10.12659/MSM.896675
Novel P Wave Indices to Predict Atrial Fibrillation Recurrence After Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
Received: 2015.11.13 Accepted: 2015.12.29 Published: 2016.07.24
Authors’ BCDEF Contribution: Xiaoliang Hu Study Design A BCD Jingzhou Jiang Data Collection B ABFG Yuedong Ma Statistical Analysis C Data Interpretation ADEFG D Anli Tang Manuscript Preparation E Literature Search F Funds Collection G
Corresponding Author: Source of support:
Background:
Material/Methods:
Results:
Conclusions:
MeSH Keywords:
Full-text PDF:
Department of Cardiology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
Anli Tang, e-mail: [email protected] This work was supported by the Science and Technology Research and Development Program of Guangdong Province (Grant No. 2012B031800296) and the Sun Yat-Sen University Clinical Research 5010 Program (No. 2007011)
Circumferential pulmonary vein isolation (CPVI) is a widely used treatment for paroxysmal atrial fibrillation (AF). Several P wave duration (PWD) parameters have been suggested to predict post-ablation recurrence, but their use remains controversial. This study aimed to identify novel P wave indices that predict post-ablation AF recurrence. We selected 171 consecutive patients undergoing CPVI for paroxysmal AF. Electrocardiography (ECG) recordings were obtained at the beginning and the end of ablation. PWD was measured in all 12 leads. The PWD variation was calculated by subtracting the pre-ablation PWD from the post-ablation PWD. PWD was significantly shortened in leads II, III, aVF, and V1 after ablation. During a mean follow-up of 19.96±4.32 months, AF recurrence occurred in 32 (18.7%) patients. No significant differences in baseline characteristics or pre- or post-ablation PWD were observed between the AF recurrence and non-recurrence groups. Patients with AF recurrence exhibited a smaller PWD variation in leads II (1.21(–0.56, 2.40) vs. –5.77(–9.10, –4.06) ms, P
Novel P Wave Indices to Predict Atrial Fibrillation Recurrence After Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
Received: 2015.11.13 Accepted: 2015.12.29 Published: 2016.07.24
Authors’ BCDEF Contribution: Xiaoliang Hu Study Design A BCD Jingzhou Jiang Data Collection B ABFG Yuedong Ma Statistical Analysis C Data Interpretation ADEFG D Anli Tang Manuscript Preparation E Literature Search F Funds Collection G
Corresponding Author: Source of support:
Background:
Material/Methods:
Results:
Conclusions:
MeSH Keywords:
Full-text PDF:
Department of Cardiology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
Anli Tang, e-mail: [email protected] This work was supported by the Science and Technology Research and Development Program of Guangdong Province (Grant No. 2012B031800296) and the Sun Yat-Sen University Clinical Research 5010 Program (No. 2007011)
Circumferential pulmonary vein isolation (CPVI) is a widely used treatment for paroxysmal atrial fibrillation (AF). Several P wave duration (PWD) parameters have been suggested to predict post-ablation recurrence, but their use remains controversial. This study aimed to identify novel P wave indices that predict post-ablation AF recurrence. We selected 171 consecutive patients undergoing CPVI for paroxysmal AF. Electrocardiography (ECG) recordings were obtained at the beginning and the end of ablation. PWD was measured in all 12 leads. The PWD variation was calculated by subtracting the pre-ablation PWD from the post-ablation PWD. PWD was significantly shortened in leads II, III, aVF, and V1 after ablation. During a mean follow-up of 19.96±4.32 months, AF recurrence occurred in 32 (18.7%) patients. No significant differences in baseline characteristics or pre- or post-ablation PWD were observed between the AF recurrence and non-recurrence groups. Patients with AF recurrence exhibited a smaller PWD variation in leads II (1.21(–0.56, 2.40) vs. –5.77(–9.10, –4.06) ms, P
![[Radiofrequency ablation for paroxysmal atrial fibrillation : Medical antiarrhythmic treatment or radiofrequency ablation in paroxysmal atrial fibrillation (MANTRA-PAF trial)].](/assets/img/hold.png)
